Cannabinoid therapy in epilepsy

Purpose of review To review the history, pharmacology, and clinical science of cannabidiol (CBD) in the treatment of epilepsy. Recent findings Phase III randomized controlled trials and prospective open label trials have provided efficacy and safety data for the use of CBD in pediatric onset severe epilepsies. The product that was studied in the vast majority of these published trials, Epidiolex (>99% of CBD and

https://ift.tt/2tILfH5